A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer ...

A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...

Discover the latest targeted therapies and clinical trials for FR-alpha–positive ovarian cancer, including antibody-drug ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells—showing strong results in ...

Targeted immunotherapy is a new direction in precision cancer therapy, with many approvals for T-cell engagers (TCEs) in hematologic malignancies. The recent approvals of tebentafusp and tarlatamab ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Nuvalent (NUVL) has secured a U.S. review for its second product in less than a year after the FDA granted priority review for its marketing application targeting the lung cancer therapy neladalkib.

Dr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or metastatic ...